Structural Formula (Esomeprazole Strontium Delayed Release Capsules 1)
Esomeprazole Strontium
Product Images NDC 53746-955
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Strontium (NDC 53746-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure2 (Esomeprazole Strontium Delayed Release Capsules 2)
Figure3 (Esomeprazole Strontium Delayed Release Capsules 3)
This is likely a table or chart with various medication dosages (Esomeprazole Magnesium) and a placebo listed with corresponding sample sizes (N values). There is also a percentage of maintenance listed, but with no context or description it is unclear what this refers to. The number "18 2 35" and the word "Month" are also present, but again without further context it is impossible to determine their meaning.*
Figure4 (Esomeprazole Strontium Delayed Release Capsules 4)
This is a chart displaying the percentage of patients who were symptom-free after taking either 44.6mg or 22.3mg of Esomeprazole Magnesium compared to a placebo over a period of 28 days with diary days labeled on the x-axis.*
Figure5 (Esomeprazole Strontium Delayed Release Capsules 5)
This is a chart showing the percentage of patients who were symptom-free of heartburn as recorded in their diary over a period of 28 days. The chart compares two doses of Esomeprazole Magnesium (44.6 mg and 223 mg) with a placebo. The percentage of patients who were symptom-free on each day is not available as there is no data recorded on the chart.*
24.65 mg Brand Label (Esomeprazole Strontium Delayed Release Capsules 6)
This is a description of a medication with the NDC code 53746-955-03. It is a delayed-release capsule containing 24.65 mg of esomeprazole strontium, which is equivalent to 20 mg of esomeprazole. The container should be kept tightly closed and out of reach of children, and stored between 20° to 25°C (68"to 77°F). Non-varnish product. The medication guide should be dispensed separately, and the usual adult dosage should be found in the package insert. The medication is licensed by Hanmi Pharm. Co. Ltd. and is distributed by Amneal Pharmaceuticals.*
49.3 mg Brand Label (Esomeprazole Strontium Delayed Release Capsules 7)
NDC 53746-957-03 is a prescription medication containing 49.3mg of esomeprazole strontium, equivalent to 40mg of esomeprazole per delayed-release capsule. It should be stored at room temperature, between 20-25°C, and kept out of reach of children. Excursions up to 15-30°C are permitted. A pharmacist should dispense the medication in a tight container, with a medication guide provided separately. Usual adult dosage should be determined based on the package insert. This medication is licensed from Hanmi Pharm. Co. Ltd, Seoul, Korea and distributed by Amneal Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
